Affluent Medical S.A.S
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00L2LLFD3
AFME
Affluent Medical S.A.S
GICS: -
·
Sector: -
·
Sub-Sector: -
NAME
Affluent Medical S.A.S
ISIN
FR0013333077
TICKER
AFME
MIC
XPAR
REUTERS
AFME.PA
BLOOMBERG
AFME FP
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Tue, 08.10.2024
PRESS RELEASE
Affluent Medical Announces Participation in Upcoming Scientific Events
Aix-en-Provence, October 8, 2024 – 5:45 p.m. CEST – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME – "Affluent"), a French clinical-stage medical technology company specializing in the international development and industrialization of implantable innovativ...
Thu, 26.09.2024
PRESS RELEASE
H1 2024 RESULTS
Major advances in all three programs
Several strategic agreements signed with the world medtech leader in cardiology
Extension of financial runway to July 2025
Several agreements signed in July 2024 with Edwards Lifesciences for an initial amount of €15m and an option to acquire the rights for KaliosTM
Positiv...
Thu, 22.08.2024
PRESS RELEASE
Affluent Medical to attend German Fall Conference in Frankfurt in September 2024
Aix-en-Provence, August 22, 2024 – 7:30 am – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME - “Affluent”), a French clinical-stage medical technology company specializing in the international development and industrialization of innovative medic...
Mon, 15.07.2024
PRESS RELEASE
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of a category of beneficiaries
Aix-en-Provence, July 15, 2024 – 7:45 a.m. - Affluent Medical (ISIN: FR0013333077 – Ticker: AFME), a Fren...
Fri, 12.07.2024
Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
Aix-en-Provence, July 12, 2024 - 7:45 am - Affluent Medical (ISIN: FR0013333077 – Ticker: AFME - “Affluent”), a French clinical-stage medical technology company specializing in the international development and industrialization of innovative medical dev...
Tue, 18.06.2024
PRESS RELEASE
Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter
Second successful implantation of the innovative Artus medical device in Krakow, Poland
Successful activation of the Artus device in the first two patients six weeks after surgery
Artus, an ...
Tue, 18.06.2024
PRESS RELEASE
Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter
Second successful implantation of the innovative Artus medical device in Krakow, Poland
Successful activation of the Artus device in the first two patients six weeks after surgery
Artus, an ...
Thu, 28.09.2023
H1 2023 RESULTS
Major advances in clinical programs
Extension of cash horizon to February 2024
Progress in structural heart activities:
First successful implantation of the Epygon valve and continuation of the pilot study
Excellent clinical results for Kalios in terms of efficacy and an excellent 1-year safety profile
Financing of clin...
Wed, 13.09.2023
PRESS RELEASE
Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities
KaliosTM adjustable ring for mitral valve repair with positive 1-year results:
- Pivotal Optimise II study with 20 patients demonstrated efficacy at 1 year and excellent safety profile
- Results drove s...
Mon, 17.07.2023
Affluent Medical strengthens management team to advance its development
Aix-en-Provence, July 17, 2023 – 07:30 am CET - Affluent Medical (Euronext Paris: FR0013333077 – AFME), a French clinical-stage MedTech company specialized in the international development and commercialization of innovative medical prostheses to treat mitral heart valve pat...
Information on product placements
